Latest News

Teva to Present at the 21st Annual Morgan Stanley Global Healthcare Conference

Teva to Present at the 21st Annual Morgan Stanley Global Healthcare Conference

Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetra...

Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetrabenaz

Teva Settles Price Fixing Charges With U.S. DOJ

Teva Settles Price Fixing Charges With U.S. DOJ

Teva Reports Second Quarter 2023 Financial Results

Teva Reports Second Quarter 2023 Financial Results

Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development

Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August...

Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2

Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained lon...

Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-ter

Teva to Present Data at the 2023 American Headache Society Annual Scientific Meeting Demonstrating A...

Teva to Present Data at the 2023 American Headache Society Annual Scientific Meeting Demonstrating AJOVY®

Teva Reaches Agreement With Kentucky to Settle the State’s Price Fixing Claims

Teva Reaches Agreement With Kentucky to Settle the State’s Price Fixing Claims

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

Teva Concludes Nationwide Opioids Settlement Agreement

Teva Concludes Nationwide Opioids Settlement Agreement

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration ...

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit a

Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Signi...

Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significan

Teva Launches New “Pivot to Growth” Strategy

Teva Launches New “Pivot to Growth” Strategy